To date, overexpressed S100A8/S100A9 proteins have already been observed in a variety of cancer types including breast cancer [35, 36], prostate cancer [37, 38], bladder cancer [39, 40], and colon cancer [41, 42]. This evidence concerns the gene S100A9 and urinary bladder carcinoma.